Wagner, J A <br/><br/>
Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jul 2015 
 - 12-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1002/cpt.129  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--analysis<br/>Chronic Disease<br/>Endpoint Determination--methods<br/>Government Agencies<br/>Guidelines as Topic<br/>Humans<br/>National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division<br/>United States<br/>United States Food and Drug Administration